Know Cancer

forgot password

National Wilm's Tumor Study Late Effects

18 Years
85 Years
Open (Enrolling)
Wilm's Tumor

Thank you

Trial Information

National Wilm's Tumor Study Late Effects

The Late Effects Study is being conducted in order to answer scientific questions and to
serve as a resource for Wilms tumor patients and their families. Although most people in
this study enjoy good health, some may be at risk for certain health conditions. We are
collecting information from as many participants as possible in order to determine if they
or their offspring are at risk for adverse medical conditions. If there is more than one
case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate
heritability and recurrence risks.

Inclusion Criteria:

Previously enrolled in NWTS 5.

Type of Study:


Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions.

Outcome Time Frame:

1 year after closure of study

Safety Issue:


Principal Investigator

Howard Katzenstein, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Children's Healthcare of Atlanta


United States: Food and Drug Administration

Study ID:




Start Date:

September 2005

Completion Date:

December 2011

Related Keywords:

  • Wilm's Tumor
  • late effects
  • Wilms Tumor



Children's Healthcare of Atlanta Atlanta, Georgia  30342